Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRIMedical - Devices
Healthcare
$14.01 +7.25%
+$0.84 today
- Market cap
- $1.35B
- Beta
- 2.18
- P/E (TTM)
- -34.3
- EPS (TTM)
- -$0.28
52W Low $6.45High $19.45
Volume 0.26M
Average 0.92M
Income Statement
Follow revenue through to earnings.
Revenue
$1.02B
FY 2025 · Annual
+7.8% YoYOperating Income
$26.73M
FY 2025 · Annual
-51.6% YoYNet Income
-$47.10M
FY 2025 · Annual
Income Statement
USD
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 935.93M | 948.87M | 1.02B |
| Cost of Revenue | 836.96M | 852.61M | 905.9M |
| Gross Profit | 98.97M | 96.26M | 117.19M |
| Gross Margin | 10.6% | 10.1% | 11.5% |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 55.17M | 70.36M | 90.45M |
| Operating Expenses | 76.52M | 41.02M | 90.45M |
| Depreciation & Amortization | 72.14M | 57.16M | 55.39M |
| EBITDA | 94.58M | 114M | 141.71M |
| EBITDA Margin | 10.1% | 12.0% | 13.9% |
| Operating Income | 22.45M | 55.24M | 26.73M |
| Operating Margin | 2.4% | 5.8% | 2.6% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 141.69M | 136.03M | 118.54M |
| Other Income / Expenses | (141.69M) | (134.44M) | (58.95M) |
| Income Before Tax | (119.25M) | (79.19M) | (32.22M) |
| Pre-Tax Margin | -12.7% | -8.3% | -3.1% |
| Income Tax Expense | 2.98M | 14.91M | 14.89M |
| Net Income | (122.23M) | (94.1M) | (47.1M) |
| Net Margin | -13.1% | -9.9% | -4.6% |
| EPS (Basic) | (1.29) | (1.00) | (0.66) |
| EPS (Diluted) | (1.29) | (1.00) | (0.66) |
| 94.57M | 94.57M | 70.98M | |
| 94.57M | 94.57M | 70.98M |
LMRI Earnings Waterfall · TTM
NASDAQ:LMRI · Revenue to Net Income
No earnings data available.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 | |
| 10-Q | Quarterly report | Aug 13, 2026 | |
| 8-K | Current report | Aug 12, 2026 |
How much revenue does LMRI generate?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) reported $1.02B of revenue in fiscal 2025.
Is LMRI profitable?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) reported -$47.10M of net income, with a net margin of -4.6%.
Continue the stock analysis
Jump to another research area for this company.